Immuneering (IMRX) Depreciation & Amortization (CF) (2020 - 2024)
Historic Depreciation & Amortization (CF) for Immuneering (IMRX) over the last 5 years, with Q4 2024 value amounting to $86116.0.
- Immuneering's Depreciation & Amortization (CF) fell 405.33% to $86116.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $355807.0, marking a year-over-year increase of 1021.98%. This contributed to the annual value of $355807.0 for FY2024, which is 1021.98% up from last year.
- According to the latest figures from Q4 2024, Immuneering's Depreciation & Amortization (CF) is $86116.0, which was down 405.33% from $88949.0 recorded in Q3 2024.
- In the past 5 years, Immuneering's Depreciation & Amortization (CF) registered a high of $90533.0 during Q2 2024, and its lowest value of $5656.0 during Q3 2020.
- Its 5-year average for Depreciation & Amortization (CF) is $52121.7, with a median of $68075.0 in 2022.
- As far as peak fluctuations go, Immuneering's Depreciation & Amortization (CF) soared by 46833.36% in 2022, and later tumbled by 405.33% in 2024.
- Quarter analysis of 5 years shows Immuneering's Depreciation & Amortization (CF) stood at $7449.0 in 2020, then soared by 98.89% to $14815.0 in 2021, then surged by 418.81% to $76862.0 in 2022, then rose by 16.77% to $89754.0 in 2023, then dropped by 4.05% to $86116.0 in 2024.
- Its Depreciation & Amortization (CF) was $86116.0 in Q4 2024, compared to $88949.0 in Q3 2024 and $90533.0 in Q2 2024.